281 related articles for article (PubMed ID: 36831578)
1. Histopathological Aspects of the Prognostic Factors for Salivary Gland Cancers.
Nishida H; Kusaba T; Kawamura K; Oyama Y; Daa T
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831578
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Impact of PD-L1 Expression in Malignant Salivary Gland Tumors as Assessed by Established Scoring Criteria: Tumor Proportion Score (TPS), Combined Positivity Score (CPS), and Immune Cell (IC) Infiltrate.
Witte HM; Gebauer N; Lappöhn D; Umathum VG; Riecke A; Arndt A; Steinestel K
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32260165
[TBL] [Abstract][Full Text] [Related]
3. [Clinical analysis of cervical lymph node metastasis of cN0 maxillary malignant tumor].
Sun Q; Zhang WB; Gao M; Yu S; Mao C; Guo CB; Yu GY; Peng X
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Dec; 49(6):1050-1054. PubMed ID: 29263480
[TBL] [Abstract][Full Text] [Related]
4. Epidemiological, Clinical, and Histopathological Features of Salivary Gland Tumors among 150 Sudanese Patients: 10 Years' Experience.
Hamid STS; Abdalla MAM; Zulfu AA; Ramadan A; Ahmed M; Ahmed MH
J Microsc Ultrastruct; 2023; 11(2):92-96. PubMed ID: 37448823
[TBL] [Abstract][Full Text] [Related]
5. Salivary gland epithelial neoplasms in pediatric population: a single-institute experience with a focus on the histologic spectrum and clinical outcome.
Xu B; Aneja A; Ghossein R; Katabi N
Hum Pathol; 2017 Sep; 67():37-44. PubMed ID: 28739497
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of DOG-1 Expression in Salivary Gland Tumours and Comparison with Myoepithelial Markers.
Khurram SA; Speight PM
Head Neck Pathol; 2019 Jun; 13(2):140-148. PubMed ID: 29671211
[TBL] [Abstract][Full Text] [Related]
7. [Carcinoma ex pleomorphic adenoma of major salivary glands--a clinicopathologic review].
Stodulski D; Rzepko R; Kowalska B; Stankiewicz C
Otolaryngol Pol; 2007; 61(5):687-93. PubMed ID: 18552001
[TBL] [Abstract][Full Text] [Related]
8. SOX10-positive salivary gland tumors: a growing list, including mammary analogue secretory carcinoma of the salivary gland, sialoblastoma, low-grade salivary duct carcinoma, basal cell adenoma/adenocarcinoma, and a subgroup of mucoepidermoid carcinoma.
Hsieh MS; Lee YH; Chang YL
Hum Pathol; 2016 Oct; 56():134-42. PubMed ID: 27327192
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous impact of smoking on major salivary gland cancer according to histopathological subtype: A case-control study.
Sawabe M; Ito H; Takahara T; Oze I; Kawakita D; Yatabe Y; Hasegawa Y; Murakami S; Matsuo K
Cancer; 2018 Jan; 124(1):118-124. PubMed ID: 28881386
[TBL] [Abstract][Full Text] [Related]
10. The oncofetal protein IMP3 is an indicator of early recurrence and poor outcome in mucoepidermoid carcinoma of salivary glands.
Elshafey MR; Ahmed RA; Mourad MI; Gaballah ET
Cancer Biol Med; 2016 Jun; 13(2):286-95. PubMed ID: 27458536
[TBL] [Abstract][Full Text] [Related]
11. A review: Immunological markers for malignant salivary gland tumors.
Namboodiripad PC
J Oral Biol Craniofac Res; 2014; 4(2):127-34. PubMed ID: 25737930
[TBL] [Abstract][Full Text] [Related]
12. The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma.
Prasad AR; Savera AT; Gown AM; Zarbo RJ
Arch Pathol Lab Med; 1999 Sep; 123(9):801-6. PubMed ID: 10458827
[TBL] [Abstract][Full Text] [Related]
13. Patterns of lymph node metastasis of parotid cancer.
Shinomiya H; Otsuki N; Yamashita D; Nibu K
Auris Nasus Larynx; 2016 Aug; 43(4):446-50. PubMed ID: 26656731
[TBL] [Abstract][Full Text] [Related]
14. Glial Fibrillary Acidic Protein Expression Helps Distinguish Pleomorphic Adenoma from Histologic Mimics.
Gorski Z; Purgina B; Wasserman JK
Head Neck Pathol; 2022 Sep; 16(3):695-702. PubMed ID: 35064902
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapies.
Ross JS; Gay LM; Wang K; Vergilio JA; Suh J; Ramkissoon S; Somerset H; Johnson JM; Russell J; Ali S; Schrock AB; Fabrizio D; Frampton G; Miller V; Stephens PJ; Elvin JA; Bowles DW
Ann Oncol; 2017 Oct; 28(10):2539-2546. PubMed ID: 28961851
[TBL] [Abstract][Full Text] [Related]
16. Comparison of p63/p40 Expression With Myoepithelial Markers in Minor Salivary Gland Tumors.
Teixeira LN; Janner ÉC; Teixeira T; Passador-Santos F; Martinez EF; Demasi APD; de Araújo NS; de Araújo VC
Int J Surg Pathol; 2019 Jun; 27(4):360-371. PubMed ID: 30482064
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of VEGF expression correlates with COX-2 expression in pleomorphic adenoma, mucoepidermoid carcinoma and adenoid cystic carcinoma.
Shamloo N; Taghavi N; Yazdani F; Azimian P; Ahmadi S
Dent Res J (Isfahan); 2020; 17(2):100-106. PubMed ID: 32435431
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic utility of PLAG1 immunohistochemical determination in salivary gland tumors.
Rotellini M; Palomba A; Baroni G; Franchi A
Appl Immunohistochem Mol Morphol; 2014; 22(5):390-4. PubMed ID: 23958548
[TBL] [Abstract][Full Text] [Related]
19. Caveolin-1 overexpression in benign and malignant salivary gland tumors.
Jaafari-Ashkavandi Z; Ashraf MJ; Nazhvani AD; Azizi Z
Tumour Biol; 2016 Feb; 37(2):1863-9. PubMed ID: 26323261
[TBL] [Abstract][Full Text] [Related]
20. Utility of neck dissection for management of carcinoma of the parotid gland.
Kaura A; Kennedy RA; Ali S; Odell E; Simo R; Jeannon JP; Oakley R
Br J Oral Maxillofac Surg; 2019 Dec; 57(10):1039-1043. PubMed ID: 31564483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
